Ignite Creation Date:
2025-12-24 @ 12:23 PM
Ignite Modification Date:
2025-12-27 @ 9:54 PM
Study NCT ID:
NCT01062061
Status:
COMPLETED
Last Update Posted:
2015-09-04
First Post:
2010-02-02
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Re-examination Study For Varivax (V210-059 AM2)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06
Start Date Type:
None
Primary Completion Date:
2012-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-05
Completion Date Type:
ACTUAL
First Submit Date:
2010-02-02
First Submit QC Date:
None
Study First Post Date:
2010-02-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-04-16
Results First Submit QC Date:
None
Results First Post Date:
2013-07-03
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-09-03
Last Update Post Date:
2015-09-04
Last Update Post Date Type:
ESTIMATED